Charles Glueck, MD
Medical Research Director of Cholesterol CenterJewish Hospital
Charles Glueck, MD, is the Medical Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, interaction of atherosclerosis and thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology, and hematology. Dr Glueck and colleagues have recent extensive published experience with ocular thrombosis, amaurosis fugax, pregnancy loss, osteonecrosis, Prinzmetal's angina, and ischemic stroke. Dr. Glueck is experienced in epidemiology and biostatistics, and design-completion of controlled clinical trials. Dr. Glueck has authored over 600 scientific papers and was an established investigator for AHA, and has been a long-term NIH grantee. Dr Glueck is on the editorial board of Circulation, and is a senior editor of Metabolism. Dr Glueck actively reviews for 25 journals. Dr. Glueck has also consulted for several major drug companies. (This is me - Update Profile)
| 1987 - present | Medical Research Director of Cholesterol Center Jewish Hospital |
|---|
GLG Study Groups with Charles Glueck, MD(?)
| Study Group Name | Members |
|---|---|
| Non-Electrophysiologist Cardiologists (US) | 832 |
| Cardiologists Specializing in Lipids (US) | 162 |
| General Cardiologists (US) | 1333 |
| Physicians who Treat Hypertension (US) | 664 |
GLG NewsSM Analyses by Charles Glueck, MD(?)
By reducing fractional catabolic rate and by producing a large, cholesterol rich HDL molecule which could not easily be cleared by hepatic HDL receptors, our research group in Cincinnati thought from the beginning that the CETP inhibitors AS A CLASS would fail, and might even be proatherogenic. Regrettably,...
GLG InstituteSM Seminars with Charles Glueck, MD(?)
Recent Seminars
Request a project with Charles Glueck, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms